semaglutide research labs GLP-1 Receptor Agonist Reference Research Compound Catalog | GLP1

FDA-approved drugs in each class GLP-1 receptor agonist medications include semaglutide (Ozempic, Wegovy, Rybelsus), tirzepatide (Mounjaro, Zepbound also a GIP agonist), liraglutide (Victoza, Saxenda), dulaglutide (Trulicity), and exenatide (Byetta, Bydureon)

The American Diabetes Association Standards of Care recommend GLP-1 receptor agonists as preferred agents for patients with type 2 diabetes who have established cardiovascular disease or indicators of high cardiovascular risk, or when weight loss is a priority

Social withdrawal dropped by 31%[2]

Differentiated Advantage Picks Products that demonstrate strong market validation or unique formulations offer a competitive edge

A small molecule inhibitor MCC950 ameliorates kidney injury in diabetic nephropathy by inhibiting NLRP3 inflammasome activation